Adele Campo
Salvatore Campo
Department of Biomedical and Dental Sciences and Morphofunctional Images, Policlinico Universitario, University of Messina, Messina 98125, Italy
More InformationCorresponding author: E-mail address: scampo@unime.it (Salvatore Campo)
Received Date: 2017-10-19
Accepted Date:2018-01-15
Rev Recd Date:2018-01-12
Available Online: 2018-02-01 Publish Date:2018-01-20
Abstract
Abstract
In eukaryotic cells, protein synthesis is a complex and multi-step process that has several mechanisms to start the translation including cap-dependent and cap-independent initiation. The translation control of eukaryotic gene expression occurs principally at the initiation step. In this context, it is critical that the eukaryotic translation initiation factor eIF4E bind to the 7-methylguanosine (m7G) cap present at the 5′-UTRs of most eukaryotic mRNAs. Combined with other initiation factors, eIF4E mediates the mRNA recruitment on ribosomes to start the translation. Moreover, the eIF4E nuclear bodies are involved in the export of specific mRNAs from the nucleus to the cytoplasm. In this review, we focus on the eIF4E structure and its physiological functions, and describe the role of eIF4E in cancer development and progression and the current therapeutic strategies to target eIF4E.Keywords: eIF4E factor,
Translation initiation,
mRNA export,
Cancer
PDF全文下载地址:
http://www.jgenetgenomics.org/article/exportPdf?id=1a0997a8-c131-43f6-a3a7-66ae0672abc9&language=en
